Medications Development for Opioid Abuse
نویسندگان
چکیده
منابع مشابه
Development and preliminary validation of the Opioid Abuse Risk Screener
Prescription opioid drug abuse has reached epidemic proportions. Individuals with chronic pain represent a large population at considerable risk of abusing opioids. The Opioid Abuse Risk Screener was developed as a comprehensive self-administered measure of potential risk that includes a wide range of critical elements noted in the literature to be relevant to opioid risk. The creation, refinem...
متن کاملAdolescent opioid abuse.
WHAT ARE OPIOIDS? When used as medications, opioids are important but powerful medications for severe pain. They are often used to reduce pain when patients are recovering from surgery or major injuries. Adverse effects of these medications can include feeling sleepy, dizzy, or confused. It is not safe to drive a vehicle after taking this type of medication. Another adverse effect is constipati...
متن کاملPrescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
Both chronic pain and prescription opioid abuse are prevalent and continue to exact a heavy toll on patients, physicians, and society. Individuals with chronic pain and co-occurring substance use disorders and/or mental health disorders, are at a higher risk for misuse of prescribed opioids. Opioid abuse and misuse occurs for a variety of reasons, including self medication, use for reward, comp...
متن کاملOpioid abuse and pain management.
Chronic nonmalignant pain affects a significant number of Americans. In addition to physical discomfort, chronic pain leads to work absenteeism, family disruption, and impairment of activities of daily living, resulting in secondary depression, social isolation, and low self-esteem, among other consequences. Concurrent with the increased need for pain management is a considerable increase in th...
متن کاملNON OPIOID ANALGESICS and ANTI-INFLAMMATORY MEDICATIONS
Paracetamol has analgesic and antipyretic e ects that are similar to aspirin, but little or no antiin ammatory activity. It is generally accepted that it has little e ect on extracerebral COX-1 or COX-2, although it inhibits central COX-3. Consequently, it prevents the enhanced synthesis of prostaglandin E2 in the hypothalamus during pyrexia, and thus reduces elevated body temperature. It has s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cold Spring Harbor Perspectives in Medicine
سال: 2012
ISSN: 2157-1422
DOI: 10.1101/cshperspect.a012104